Latest REGN reports update at 2024-05-02: 2024-Q1 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Regeneron Pharmaceuticals
  4. Financial Ratios
  5. EV/EBITDA Ratio
Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals REGN
$ 968.0 1.28%
mail-toReport an Error

Regeneron Pharmaceuticals EV/EBITDA Ratio 2011-2024 | REGN

Annual EV/EBITDA Ratio Regeneron Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
7.63 13.9 14.5 16.3 17.8 24.8 32 46.5 35.5 33.6 -45.1

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
46.5 -45.1 18